{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T13:18:11Z","timestamp":1789823891727,"version":"4.0.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>This study examined long-term improvement of quality of life amongst heroin users enrolled in methadone maintenance treatment (MMT).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The sample contained 553 heroin-dependent individuals from 4 hospitals in northern Taiwan who enrolled in MMT for an average of 184 days. Each patient signed a consent form and was assessed prospectively 3 times semi-annually. Quality of life was measured using the WHOQOL-BREF questionnaire, 26 items of which were scored by the participants. The WHOQOL-BREF consists of four domains: physical, psychological, social, and environmental. 285 and 155 participants completed 6-month and 12-month follow-ups respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>After controlling for demographic and clinical characteristics, there were statistically significant improvements in the psychological and environmental domains between baseline and 6 months. Significant improvements were found in psychological and social domains between baseline and 12 months.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>It is concluded that methadone maintenance treatment improves heroin users\u2019 long-term quality of life in the psychological and social relationship domains.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-244x-13-190","type":"journal-article","created":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T18:14:21Z","timestamp":1373998461000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Improvement of quality of life in methadone treatment patients in northern Taiwan: a follow-up study"],"prefix":"10.1186","volume":"13","author":[{"given":"Ying-Chun","family":"Chou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Fang","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Der","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiang-shan R","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony Szu-Hsien","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,16]]},"reference":[{"key":"1374_CR1","volume-title":"Drug facts: Heroin: National Institute on Drug Abuse","author":"National Institute on Drug Abuse","year":"2010","unstructured":"National Institute on Drug Abuse: Drug facts: Heroin: National Institute on Drug Abuse. 2010, http:\/\/www.drugabuse.gov\/publications\/drugfacts\/heroin,"},{"key":"1374_CR2","doi-asserted-by":"crossref","DOI":"10.18356\/94bbf1f4-en","volume-title":"World drug report 2012","author":"United Nations Office on Drugs and Crime","year":"2012","unstructured":"United Nations Office on Drugs and Crime: World drug report 2012. 2012, http:\/\/www.unodc.org\/documents\/data-and-analysis\/WDR2012\/WDR_2012_web_small.pdf,"},{"key":"1374_CR3","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/eurpub\/cki168","volume":"16","author":"AM Bargagli","year":"2006","unstructured":"Bargagli AM, Hickman M, Davoli M, Perucci CA, Schifano P, Buster M, Brugal T, Vicente J: Drug-related mortality and its impact on adult mortality in eight European countries. Eur J Publ Health. 2006, 16: 198-202.","journal-title":"Eur J Publ Health"},{"key":"1374_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1177\/002204260703700105","volume":"37","author":"P Lejckova","year":"2007","unstructured":"Lejckova P, Mravcik V: Mortality of hospitalized drug users in the Czech Republic. J Drug Issues. 2007, 37: 103-118. 10.1177\/002204260703700105.","journal-title":"J Drug Issues"},{"issue":"Suppl 3","key":"1374_CR5","first-page":"iii56","volume":"82","author":"L Degenhardt","year":"2006","unstructured":"Degenhardt L, Hall W, Warner-Smith M: Using cohort studies to estimate mortality among injecting drug users that is not attributable to AIDS. Sex Transm Infect. 2006, 82 (Suppl 3): iii56-iii63.","journal-title":"Sex Transm Infect"},{"key":"1374_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1747-597X-6-6","volume":"6","author":"TS Lee","year":"2011","unstructured":"Lee TS, Shen HC, Wu WH, Huang CW, Yen MY, Wang BE, Chuang P, Shih CY, Chou YC, Liu YL: Clinical characteristics and risk behavior as a function of HIV status among heroin users enrolled in methadone treatment in northern Taiwan. Subst Abuse Treat Prev Pol. 2011, 6: 6-10.1186\/1747-597X-6-6.","journal-title":"Subst Abuse Treat Prev Pol"},{"key":"1374_CR7","doi-asserted-by":"publisher","first-page":"e3608","DOI":"10.1371\/journal.pone.0003608","volume":"3","author":"Y Tan","year":"2008","unstructured":"Tan Y, Wei QH, Chen LJ, Chan PC, Lai WS, He ML, Kung HF, Lee SS: Molecular epidemiology of HCV monoinfection and HIV\/HCV coinfection in injection drug users in Liuzhou, Southern China. PLoS One. 2008, 3: e3608-10.1371\/journal.pone.0003608.","journal-title":"PLoS One"},{"key":"1374_CR8","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1111\/j.1360-0443.2009.02894.x","volume":"105","author":"CY Chen","year":"2010","unstructured":"Chen CY, Wu PN, Su LW, Chou YJ, Lin KM: Three-year mortality and predictors after release: a longitudinal study of first-time drug offenders in Taiwan. Addiction. 2010, 105: 920-927. 10.1111\/j.1360-0443.2009.02894.x.","journal-title":"Addiction"},{"key":"1374_CR9","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.drugalcdep.2011.04.004","volume":"118","author":"CE Grella","year":"2011","unstructured":"Grella CE, Lovinger K: 30-year trajectories of heroin and other drug use among men and women sampled from methadone treatment in California. Drug Alcohol Depend. 2011, 118: 251-258. 10.1016\/j.drugalcdep.2011.04.004.","journal-title":"Drug Alcohol Depend"},{"key":"1374_CR10","volume-title":"Drug facts: Understanding drug abuse and addiction: National Institute on Drug Abuse","author":"National Institute on Drug Abuse","year":"2011","unstructured":"National Institute on Drug Abuse: Drug facts: Understanding drug abuse and addiction: National Institute on Drug Abuse. 2011, http:\/\/www.drugabuse.gov\/publications\/drugfacts\/understanding-drug-abuse-addiction,"},{"key":"1374_CR11","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jsat.2006.03.014","volume":"31","author":"TP O'Toole","year":"2006","unstructured":"O'Toole TP, Pollini RA, Ford D, Bigelow G: Physical health as a motivator for substance abuse treatment among medically ill adults: is it enough to keep them in treatment?. J Subst Abuse Treat. 2006, 31: 143-150. 10.1016\/j.jsat.2006.03.014.","journal-title":"J Subst Abuse Treat"},{"key":"1374_CR12","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.drugalcdep.2011.01.008","volume":"117","author":"SM Kelly","year":"2011","unstructured":"Kelly SM, O\u2019Grady KE, Mitchell SG, Brown BS, Schwartz RP: Predictors of methadone treatment retention from a multi-site study: A survival analysis. Drug Alcohol Depend. 2011, 117: 170-175. 10.1016\/j.drugalcdep.2011.01.008.","journal-title":"Drug Alcohol Depend"},{"key":"1374_CR13","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.drugalcdep.2005.11.020","volume":"83","author":"SW Villafranca","year":"2006","unstructured":"Villafranca SW, McKellar JD, Trafton JA, Humphreys K: Predictors of retention in methadone programs: A signal detection analysis. Drug Alcohol Depend. 2006, 83: 218-224. 10.1016\/j.drugalcdep.2005.11.020.","journal-title":"Drug Alcohol Depend"},{"key":"1374_CR14","first-page":"347","volume":"67","author":"H Joseph","year":"2000","unstructured":"Joseph H, Stancliff S, Langrod J: Methadone maintenance treatment (MMT): a review of historical and clinical issues. Mt Sinai J Med. 2000, 67: 347-364.","journal-title":"Mt Sinai J Med"},{"key":"1374_CR15","volume-title":"Drug facts: Treatment approaches for drug addiction","author":"National Institute on Drug Abuse","year":"2009","unstructured":"National Institute on Drug Abuse: Drug facts: Treatment approaches for drug addiction. 2009, http:\/\/www.drugabuse.gov\/publications\/drugfacts\/treatment-approaches-drug-addiction,"},{"key":"1374_CR16","doi-asserted-by":"publisher","first-page":"526","DOI":"10.7326\/0003-4819-127-7-199710010-00004","volume":"127","author":"PG O'Connor","year":"1997","unstructured":"O'Connor PG, Carroll KM, Shi JM, Schottenfeld RS, Kosten TR, Rounsaville BJ: Three methods of opioid detoxification in a primary care setting: A randomized trial. Ann Intern Med. 1997, 127: 526-530. 10.7326\/0003-4819-127-7-199710010-00004.","journal-title":"Ann Intern Med"},{"key":"1374_CR17","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1037\/1064-1297.14.2.157","volume":"14","author":"SA Gruber","year":"2006","unstructured":"Gruber SA, Tzilos GK, Silveri MM, Pollack M, Renshaw PF, Kaufman MJ, Yurgelun-Todd DA: Methadone maintenance improves cognitive performance after two months of treatment. Exp Clin Psychopharmacol. 2006, 14: 157-164.","journal-title":"Exp Clin Psychopharmacol"},{"issue":"Suppl 1","key":"1374_CR18","doi-asserted-by":"publisher","first-page":"S116","DOI":"10.1097\/QAI.0b013e3181c7dfb5","volume":"53","author":"L Xiao","year":"2010","unstructured":"Xiao L, Wu Z, Luo W, Wei X: Quality of life of outpatients in methadone maintenance treatment clinics. J Acquir Immune Defic Syndr. 2010, 53 (Suppl 1): S116-S120.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"1374_CR19","volume-title":"Monthly report on drug substance treatment (In Mandarin)","author":"Centers for Disease Control Taiwan","year":"2012","unstructured":"Centers for Disease Control Taiwan: Monthly report on drug substance treatment (In Mandarin). 2012, http:\/\/www2.cdc.gov.tw\/ct.asp?xItem=22061&ctNode=1885&mp=1,"},{"key":"1374_CR20","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/10826080802714462","volume":"44","author":"AB Laudet","year":"2009","unstructured":"Laudet AB, Becker JB, White WL: Don't wanna go through that madness no more: quality of life satisfaction as predictor of sustained remission from illicit drug misuse. Subst Use Misuse. 2009, 44: 227-252. 10.1080\/10826080802714462.","journal-title":"Subst Use Misuse"},{"key":"1374_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jsat.2006.11.009","volume":"33","author":"I Maremmani","year":"2007","unstructured":"Maremmani I, Pani PP, Pacini M, Perugi G: Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients. J Subst Abuse Treat. 2007, 33: 91-98. 10.1016\/j.jsat.2006.11.009.","journal-title":"J Subst Abuse Treat"},{"key":"1374_CR22","first-page":"235","volume":"43","author":"Z Padaiga","year":"2007","unstructured":"Padaiga Z, Subata E, Vanagas G: Outpatient methadone maintenance treatment program. Quality of life and health of opioid-dependent persons in Lithuania. Med (Kaunas). 2007, 43: 235-241.","journal-title":"Med (Kaunas)"},{"key":"1374_CR23","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1080\/00952990701523698","volume":"33","author":"AM Ponizovsky","year":"2007","unstructured":"Ponizovsky AM, Grinshpoon A: Quality of life among heroin users on buprenorphine versus methadone maintenance. Am J Drug Alcohol Abuse. 2007, 33: 631-642. 10.1080\/00952990701523698.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"1374_CR24","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.drugpo.2010.01.010","volume":"21","author":"J De Maeyer","year":"2010","unstructured":"De Maeyer J, Vanderplasschen W, Broekaert E: Quality of life among opiate-dependent individuals: A review of the literature. Int J Drug Pol. 2010, 21: 364-380. 10.1016\/j.drugpo.2010.01.010.","journal-title":"Int J Drug Pol"},{"key":"1374_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1477-7517-10-3","volume":"10","author":"F Yang","year":"2013","unstructured":"Yang F, Lin P, Li Y, He Q, Long Q, Fu X, Luo Y: Predictors of retention in community-based methadone maintenance treatment program in Pearl River Delta, China. Harm Reduct J. 2013, 10: 3-10.1186\/1477-7517-10-3.","journal-title":"Harm Reduct J"},{"key":"1374_CR26","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1017\/S0033291798006667","volume":"28","author":"The WHOQOL Group","year":"1998","unstructured":"The WHOQOL Group: Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med. 1998, 28: 551-558.","journal-title":"Psychol Med"},{"key":"1374_CR27","first-page":"315","volume":"19","author":"WHOQOL-Tawian Group","year":"2000","unstructured":"WHOQOL-Tawian Group: Introduction to the development of the WHOQOL\u2014Taiwan version (In Mandarin). Chin J Publ Health. 2000, 19: 315-324.","journal-title":"Chin J Publ Health"},{"key":"1374_CR28","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1747-597X-7-32","volume":"7","author":"N Baharom","year":"2012","unstructured":"Baharom N, Hassan MR, Ali N, Shah SA: Improvement of quality of life following 6 months of methadone maintenance therapy in Malaysia. Subst Abuse Treat Prev Pol. 2012, 7: 32-10.1186\/1747-597X-7-32.","journal-title":"Subst Abuse Treat Prev Pol"},{"key":"1374_CR29","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3109\/00952990.2011.649222","volume":"38","author":"PW Wang","year":"2012","unstructured":"Wang PW, Wu HC, Yen CN, Yeh YC, Chung KS, Chang HC, Yen CF: Change in quality of life and its predictors in heroin users receiving methadone maintenance treatment in Taiwan: an 18-month follow-up study. Am J Drug Alcohol Abuse. 2012, 38: 213-219. 10.3109\/00952990.2011.649222.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"1374_CR30","volume-title":"The 4th International Conference on Reproductive Health and Social Sciences Research. Bangkok, Thailand","author":"NTT Ha","year":"2010","unstructured":"Ha NTT: The effect of methadone maintenance treatment in improvement of quality of life for heroin users in Hai Phong, Vietnam. The 4th International Conference on Reproductive Health and Social Sciences Research. Bangkok, Thailand. 2010"},{"key":"1374_CR31","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3109\/10550490903205652","volume":"18","author":"PJ Carpentier","year":"2009","unstructured":"Carpentier PJ, Krabbe PF, van Gogh MT, Knapen LJ, Buitelaar JK, de Jong CA: Psychiatric comorbidity reduces quality of life in chronic methadone maintained patients. Am J Addict. 2009, 18: 470-480. 10.3109\/10550490903205652.","journal-title":"Am J Addict"},{"key":"1374_CR32","first-page":"3","volume":"4","author":"TSH Lee","year":"2013","unstructured":"Lee TSH, Shiu CS, Tuan YC, Wu WH, Huang CW, Yen MY, Lin CH, Shen LC, Lin CK: Quality of life among injection drug users living with or without HIV\/AIDS in Taiwan: A case control group design. J AIDS Clin Res. 2013, 4: 3-","journal-title":"J AIDS Clin Res"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-13-190.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-244X-13-190\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-13-190","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-13-190.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:51:16Z","timestamp":1630543876000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/1471-244X-13-190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,16]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1374"],"URL":"https:\/\/doi.org\/10.1186\/1471-244x-13-190","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,16]]},"assertion":[{"value":"20 March 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"190"}}